Search by API Index

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Impurities available for Ruxolitinib

Ruxolitinib, sold under the brand names Jakafi, Jakavi, and Opzelura is a medication used for the treatment of intermediate or high-risk myelofibrosis,a type of myeloproliferative disorder that affects the bone marrow; polycythemia vera (PCV), when there has been an inadequate response to or intolerance of hydroxyurea;and steroid-refractory acute graft-versus-host disease.Ruxolitinib is a Janus kinase inhibitor. It was developed and marketed by Incyte Corp in the US under the brand name Jakafi,and by Novartis elsewhere in the world, under the brand name Jakavi. . Anant Labs manufacture and furnish high quality Ruxolitinib impurities for global markets. Our Ruxolitinib EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide. Anant Labs offers Ruxolitinib impurities.

• 

  4-(1H-Pyrazol-4-yl)-7-[2-(trimethylsilyl)ethoxy]methyl-7 H-pyrrolo[2,3-d]-pyrimidine

  CAT Number: ANT-RXL-01

  CAS Number: 941685-27-4

  Stock: In-stock

  View Details
• 

  N-Nitroso-Ruxolitinib

  CAT Number: ANT-RXL-02

  CAS Number: NA

  Stock: Under Synthesis

  View Details